Candida auris: Disinfectants and Implications for Infection Control
- PMID: 29706945
- PMCID: PMC5906573
- DOI: 10.3389/fmicb.2018.00726
Candida auris: Disinfectants and Implications for Infection Control
Abstract
Candida auris is a rapidly emerging pathogen and is able to cause severe infections with high mortality rates. It is frequently misidentified in most clinical laboratories, thus requiring more specialized identification techniques. Furthermore, several clinical isolates have been found to be multidrug resistant and there is evidence of nosocomial transmission in outbreak fashion. Appropriate infection control measures will play a major role in controlling the management and spread of this pathogen. Unfortunately, there are very few data available on the effectiveness of disinfectants against C. auris. Chlorine-based products appear to be the most effective for environmental surface disinfection. Other disinfectants, although less effective than chlorine-based products, may have a role as adjunctive disinfectants. A cleaning protocol will also need to be established as the use of disinfectants alone may not be sufficient for maximal decontamination of patient care areas. Furthermore, there are fewer data on the effectiveness of antiseptics against C. auris for patient decolonization and hand hygiene for healthcare personnel. Chlorhexidine gluconate has shown some efficacy in in vitro studies but there are reports of patients with persistent colonization despite twice daily body washes with this disinfectant. Hand hygiene using soap and water, with or without chlorhexidine gluconate, may require the subsequent use of alcohol-based hand sanitizer for maximal disinfection. Further studies will be needed to validate the currently studied disinfectants for use in real-world settings.
Keywords: Candida auris; antiseptics; biocides; decolonization; disinfectants; hand hygiene; infection control.
Similar articles
-
In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris.Mycoses. 2017 Nov;60(11):758-763. doi: 10.1111/myc.12699. Epub 2017 Sep 15. Mycoses. 2017. PMID: 28872735
-
Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions.J Hosp Infect. 2017 Dec;97(4):363-370. doi: 10.1016/j.jhin.2017.09.009. Epub 2017 Sep 19. J Hosp Infect. 2017. PMID: 28939316
-
Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.J Hosp Infect. 2017 Dec;97(4):371-375. doi: 10.1016/j.jhin.2017.08.019. Epub 2017 Sep 1. J Hosp Infect. 2017. PMID: 28865738
-
The Epidemiology and Prevention of Candida auris.Curr Infect Dis Rep. 2019 May 1;21(6):19. doi: 10.1007/s11908-019-0675-8. Curr Infect Dis Rep. 2019. PMID: 31044272 Review.
-
Skin and hard surface disinfection against Candida auris - What we know today.Front Med (Lausanne). 2024 Feb 7;11:1312929. doi: 10.3389/fmed.2024.1312929. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38384416 Free PMC article. Review.
Cited by
-
Biocidal Resistance in Clinically Relevant Microbial Species: A Major Public Health Risk.Pathogens. 2021 May 14;10(5):598. doi: 10.3390/pathogens10050598. Pathogens. 2021. PMID: 34068912 Free PMC article. Review.
-
Study of the Chemical Profile and Anti-Fungal Activity against Candida auris of Cinnamomum cassia Essential Oil and of Its Nano-Formulations Based on Polycaprolactone.Plants (Basel). 2023 Jan 12;12(2):358. doi: 10.3390/plants12020358. Plants (Basel). 2023. PMID: 36679069 Free PMC article.
-
Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-20171.Emerg Infect Dis. 2019 Sep;25(9):1698-1707. doi: 10.3201/eid2509.190040. Emerg Infect Dis. 2019. PMID: 31441749 Free PMC article.
-
First Cases of Candida auris in a Referral Intensive Care Unit in Piedmont Region, Italy.Microorganisms. 2022 Jul 27;10(8):1521. doi: 10.3390/microorganisms10081521. Microorganisms. 2022. PMID: 36013939 Free PMC article.
-
Induction of amphotericin B resistance in susceptible Candida auris by extracellular vesicles.Emerg Microbes Infect. 2022 Dec;11(1):1900-1909. doi: 10.1080/22221751.2022.2098058. Emerg Microbes Infect. 2022. PMID: 35786393 Free PMC article.
References
-
- Andes D. R., Safdar N., Baddley J. W., Alexander B., Brumble L., Freifeld A., et al. (2016). The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl. Infect. Dis. 18 921–931. 10.1111/tid.12613 - DOI - PubMed
-
- Arendrup M. C., Prakash A., Meletiadis J., Sharma C., Chowdhary A. (2017). Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob. Agents Chemother. 61:e485-17. 10.1128/AAC.00485-17 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources